NCT02099851

Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study

Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study.

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: Noblewell · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective, observational, multicenter trial to evaluate the safety and feasibility of selective endovascular unilateral carotid body ablation in patients with treatment-resistant hypertension. All patients will be followed for two (2) years following treatment.

Detailed description

The investigators propose a new method of treatment, unilateral carotid body ablation, for treatment- resistant hypertensive patients to restore more normal blood pressure control, which will reduce cardiovascular morbidity and mortality in these patients. This strategy will increase the number of therapeutic options available to many patients and their physicians as well as offering the potential of normal blood pressure to those patients in whom blood pressure remains elevated despite vigorous, drug or device based therapies.

Conditions

• Hypertension

Interventions

Type	Name	Description
DEVICE	Carotid body ablation (Cibiem)

Timeline

• Start date: 2014-03-01
• Primary completion: 2016-12-01
• First posted: 2014-03-31
• Last updated: 2016-10-17

Locations

2 sites across 2 countries: Czechia, Poland